This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Laboratorios Del Dr. Esteve S.a., Laboratories Del Dr. Esteve S.a.. Active years: 2010-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- C. M. Hofbauer-G, AT (2010)
- C.M. Hofbauer, AT (2012)
- Maria Enzersdorf, AT (2012 - 2013)
Company Filing History:
3 out of 150 
1 out of 23 Years Active: 2010-2013
Title: The Innovative Mind of Christian Laggner
Introduction
Christian Laggner, based in Maria Enzersdorf, Austria, is an accomplished inventor recognized for his significant contributions to the field of pharmaceutical research. With a total of four patents to his name, Laggner has developed important compounds with potential therapeutic applications, particularly targeting the sigma receptor.
Latest Patents
Among Laggner's latest innovations are patents related to sigma receptor inhibitors. These inventions describe compounds of formula (I) that demonstrate pharmacological activity towards the sigma receptor. The patents detail processes for the preparation of these compounds, pharmaceutical compositions that contain them, and their use in the treatment and prophylaxis of diseases associated with the sigma receptor.
Career Highlights
Christian Laggner has worked with notable organizations in the pharmaceutical industry, including Laboratorios del Dr. Esteve S.A. His extensive experience in research and development has played a crucial role in advancing the understanding and treatment of conditions influenced by sigma receptor activity.
Collaborations
Laggner has collaborated with talented professionals such as Joerg Holenz and Maria Montserrat Contijoch-Llobet. These partnerships have contributed to his work, fostering a collaborative atmosphere that enhances innovation and research initiatives in his field.
Conclusion
With his innovative spirit and dedication to advancing pharmacological research, Christian Laggner continues to make strides in the development of sigma receptor inhibitors and related compounds. His work not only reflects his commitment to science but also offers hope for new therapeutic avenues in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile